Kai Schulze

Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research

Affiliated withHelmholtz Centre for Infection Research

Research Area

Biography

Kai Schulze has not added Biography.
If you are Kai Schulze and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2018

Other Publications

Article	Year
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties. Vaccine\| PubMed ID: 17187906	2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant. Clinical and vaccine immunology : CVI\| PubMed ID: 17567766	2007
A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17675464	2007
The FAI protein of group C streptococci acts as a mucosal adjuvant by the specific targeting and activation of B cells. International journal of medical microbiology : IJMM\| PubMed ID: 17884726	2008
Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant. Vaccine\| PubMed ID: 21619907	2011
Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology. Environmental microbiology\| PubMed ID: 22676396	2013
Vaccine adjuvants: key tools for innovative vaccine design. Current topics in medicinal chemistry\| PubMed ID: 24066891	2013
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge. PloS one\| PubMed ID: 25140692	2014
Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 25200611	2015
Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 25795506	2015
Rodents as pre-clinical models for predicting vaccine performance in humans. Expert review of vaccines\| PubMed ID: 26268433	2015
Modeling Influenza Virus Infection: A Roadmap for Influenza Research. Viruses\| PubMed ID: 26473911	2015
Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 27262025	2016
New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy. Current topics in microbiology and immunology\| PubMed ID: 27370343	2016
Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi. PLoS neglected tropical diseases\| PubMed ID: 28234897	2017
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. Journal of virology\| PubMed ID: 28592537	2017
Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway. EBioMedicine\| PubMed ID: 28754303	2017
Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 28887213	2017
Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 28935594	2017
Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Frontiers in immunology\| PubMed ID: 29033942	2017